Background Disruptions of vaginal microbiota might increase women's susceptibility to HIV infection. Advances in molecular microbiology have enabled detailed examination of associations between vaginal bacteria and HIV acquisition. Therefore, this study aimed to evaluate the association between the concentrations of specific vaginal bacteria and increased risk of HIV acquisition in African women.
Introduction
Compared with other parts of the world, where men account for most new infections, 56% of new HIV infections in Africa in 2015 were in women. 1 Bacterial vaginosis, a condition characterised by the presence of complex anaerobic vaginal bacterial communities, might contribute to HIV transmission and the disproportionate burden of HIV infection in African women. 2 The specific bacteria underlying the association between bacterial vaginosis and HIV infection remain poorly understood.
Advances in molecular microbiology have enhanced the understanding of normal and dysbiotic human microbiota. 3 These approaches have facilitated identification of distinct vaginal bacterial community types, ranging from low diversity and lactobacillus-dominated bacterial com munities to heterogeneous and highly diverse bacterial vaginosis-associated communities, characterised by an abundance of anaerobic species. [3] [4] [5] Bacterial species vary in terms of their associations with bacterial vaginosis, 6 particular symptoms, 7 and vaginal inflammation. 8 A recent study from South Africa showed that young women with high-diversity vaginal bacterial communities had increased numbers of activated genital mucosal CD4-positive T cells and a four-times increased risk of HIV acquisition compared with women with lowdiversity Lactobacillus crispatus-dominated communities. 9 Increased relative abundance of several bacterial taxa (Prevotella melaninogenica, Veillonella montpellierensis, Mycoplasma, Prevotella bivia, and Sneathia sanguinegens) were also associated with increased risk. One limitation of relative abundance data is that they do not provide absolute concentrations of bacteria, which can vary widely in women with the same relative abundance. Therefore in this study, we test the hypothesis that concentrations of specific vaginal bacteria are associated with increased risk of HIV acquisition in African women.
Methods

Study design and participants
We did a nested case-control study of participants from five cohorts in eastern and southern Africa. In the Mombasa Cohort, 10 we included women who were aged 16 years or older, HIV seronegative, and self-identified as exchanging sex for cash or in-kind payment. In the Mama Salama Study, 11 we included women who were aged 14 years or older, pregnant, and HIV seronegative either at enrolment or documented during routine antenatal care within the past 3 months. In the three cohorts of HIV-serodiscordant heterosexual couples (the Partners in Prevention Herpes Simplex Virus/HIV Transmission Study, 12 the Couples Observational Study, 13 and the Partners Pre-Exposure Prophylaxis Study), 14 we included women who were aged 18 years or older, HIV seronegative, and had an HIV-seropositive male partner aged 18 years or older. We have published detailed procedures for each cohort. [10] [11] [12] [13] [14] Each protocol has received approval from country-specific and investigator-affiliated ethical review boards, and participants provided written informed consent.
Procedures
We enrolled and collected demographic, medical, and sexual history data, as well as vaginal samples for microbiota analyses across all cohorts. We assessed and treated for sexually transmitted infections at baseline using standard regimens for the respective countries. We asked participants to return every 1-3 months for HIV testing at the respective research clinics. We defined women who acquired HIV as cases, and we compared them with women without HIV infection (matched controls) from the same cohort. Additionally, we evaluated plasma samples using nucleic acid amplification tests from pre-seroconversion visits in women who seroconverted for antibodies to HIV infection. We used these data, together with HIV serology results, to identify the first visit with evidence of HIV infection (serum anti-HIV antibody or plasma HIV RNA, or both). We selected pre-HIV-infection genital samples from visits at which participants were
Research in context
Evidence before this study We did a PubMed search on Nov 22, 2017, using the search terms "((((vagina*) AND bacteria*) AND HIV) AND acquisition) NOT review", without any date or language restrictions. The search returned 80 articles, of which nine addressed the hypothesis that vaginal microbiota might influence women's risk of acquiring HIV infection. All five prospective cohort studies in this group found that bacterial vaginosis was associated with increased risk of HIV acquisition. A single recent cohort study from South Africa used broad range bacterial PCR with deep sequencing to characterise the vaginal microbiome. In this cohort, young women with high-diversity vaginal bacterial communities had increased risk of HIV acquisition compared with women with low-diversity Lactobacillus crispatus-dominated communities. Higher relative abundances of Prevotella melaninogenica, Veillonella montpellierensis, Mycoplasma, Prevotella bivia, and Sneathia sanguinegens were also associated with increased risk of HIV acquisition. Individual bacterial species were not measured using quantitative PCR methods that are more sensitive compared with deep sequencing approaches, and allow for assessment of absolute concentrations. Further research is needed to clarify the relationship between individual bacterial quantities and women's risk of HIV acquisition.
Added value of this study
This study was a large nested case-control study of women from diverse regions within Africa and represented three important risk groups: female sex workers, pregnant and post-partum women, and HIV-negative women in serodiscordant relationships. This study is the first to show significant associations between the concentrations of specific vaginal bacteria and women's risk of HIV acquisition. The use of broad range PCR with deep sequencing to identify bacterial taxa for further study followed by taxon-directed real-time PCR to test the hypotheses related to individual bacterial taxa illustrates the value of this sequential experimental approach in microbiome studies.
Implications of all the available evidence
Concentrations of key vaginal bacteria were strongly associated with women's risk of acquiring HIV. High concentrations of some bacteria were substantially more predictive of HIV risk compared with a microscopic diagnosis of bacterial vaginosis. Key bacteria could increase HIV susceptibility through multiple potential pathways, including inflammation, production of HIV inducing factors, and disruption of physical and chemical barriers to infection. Defining vaginal bacterial taxa associated with HIV risk could point to mechanisms influencing HIV susceptibility and provide important targets for future prevention research.
both HIV antibody negative and HIV RNA negative. All participants received risk-reduction education and free condoms. Table 1 provides additional details about the procedures for each cohort.
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Microbiota analyses
We collected vaginal samples for microbiota analyses using vaginal swabs for DNA extraction and bacterial PCR. These samples were stored at -80°C and transported on dry ice to the Fred Hutchinson Cancer Research Center (Seattle, WA, USA) for analysis. The appendix (pp 1-3) provides details about the laboratory methods used. However, to summarise, a sequential approach was used in these experiments. First, broadrange 16S rRNA gene PCR with pyrosequencing was done for a subset of all cases and one randomly selected control per case. These data illustrated the overall distribution of bacterial taxa in cases versus controls. Second, relative abundance data were used to identify key bacteria to analyse with use of real-time (rt) PCR in all cases and controls.
Statistical analysis
This study targeted at least 80 cases and 240 controls. Assuming an α level of 0·05, this sample size provides more than 90% power to detect a 2·6-times difference or more in the odds of detecting a vaginal bacterial taxon in cases versus controls, assuming 20% prevalence or more of the organism in controls.
The first step of the analysis, using deep sequencing data from 55 cases and 55 matched controls, generated a large number of tests of association, so we considered this step to be hypothesis generating. On the basis of initial comparisons, we selected 20 bacteria for directed hypothesis testing using rtPCR in all cases and controls.
Pyrosequencing data were used to calculate two measures of bacterial community structure. The Chao1 Index provides an estimate of community richness, reflecting the number of different taxa. 16 The Shannon Diversity Index is a measure of diversity accounting for both the number of different taxa and the evenness of their distribution. 17 We calculated statistics of ecological diversity and richness separately for each sample using . ‡For each case, we selected three controls from the same cohort who remained HIV negative, matched in calendar time to the cases, by randomly selecting from among all HIV-negative participants who contributed a follow-up visit with a vaginal swab for microbiota analyses within 28 days after or before the case's exposure swab date. In addition to cases in women who were HIV negative at enrolment, the Mombasa Cohort and the Mama Salama Study included women defined as having acute HIV infection (ie, positive NAAT but a negative plasma antibody or rapid HIV test at enrolment). The Mama Salama Study also included enrolment of seroconverters with a documented negative HIV rapid test less than 3 months before enrolment, and both a positive rapid test and positive NAAT for HIV at enrolment. Because all of these women were newly diagnosed, none were on antibiotic prophylaxis. §Pregnant women were enrolled at any stage of gestation. During pregnancy, they were asked to return at 20, 24, 32, and 36 weeks of gestation. Following delivery, they were asked to return at 2, 6, 10, and 14 weeks, as well as at 6 and 9 months post partum. ¶At each visit, testing for HIV was done with use of the first-generation Gen-Probe HIV viral load assay (Hologic/Gen-Probe, San Diego, CA, USA). ||Herpes suppression with acyclovir did not significantly reduce HIV transmission risk compared with placebo, so women in both trial groups were eligible for the present analysis. **Gen-Probe cervical collection swab sample collected in Gen-Probe medium (Hologic/Gen-Probe, San Diego, CA, USA). Female genital microbiome studies provided similar results with cervical and vaginal swabs. 15 Swabs were placed on ice after collection and transported to a central laboratory for inventory and storage at -80°C. † †Dual rapid HIV antibody tests were done at the clinic and confirmed with HIV enzyme immunoassay. HIV serostatus at enrolment visits for all participants and at follow-up visits for HIV seroconverters was assessed with use of western blot (Genetics Systems HIV, Hercules, CA, USA) at the University of Washington (Seattle, WA, USA) in batch at the end of each study. ‡ ‡For each HIV-serodiscordant couples cohort, a pool of non-seroconverting controls was identified that was frequency-matched by biological sex and site to represent the distribution of the enrolled study cohort. Controls for this study were then selected at random from each cohort's set of controls to match a three-to-one ratio of controls to cases. § §One participant initially identified to be a case was not confirmed on HIV testing done at the conclusion of the trial. This putative case was removed from the analysis. Because this cohort of HIV-serodiscordant couples used frequency matching of controls, no controls were excluded after removing that case. However, two controls were excluded for not having a swab at the relevant visit. ¶ ¶Participants randomly allocated to PrEP had a reduction in HIV acquisition risk compared with those randomly allocated to placebo; therefore, only women in the placebo group were eligible for the present analysis. ||||COPAN flocked swabs (COPAN Diagnostics, Murrieta, CA, USA) were used and placed on ice after collection, and transported to a central laboratory for inventory and storage at -80°C. read numbers classified to their most specific taxonomic rank, using implementations of the R microbiome package (version 3.3.2). We compared index values in cases and controls using Wilcoxon rank-sum tests.
To identify potentially important species for quantitative analysis, we applied unadjusted logistic regression to the relative abundance data, with case status as the outcome and relative abundance percentage for each taxon separately as the exposure. To select the subset for rtPCR testing, we ranked the bacteria identified through pyrosequencing in descending order by score statistic using logistic models run on each taxon in rank order of score statistic until a p value of 0·2 was reached in the univariate logistic regressions. 16 bacteria were identified for further study using rtPCR on the basis of the magnitude of odds ratios (ORs) in logistic regression. The Parvimonas taxon was represented by rtPCR assays to detect species types 1 and 2, both of which were linked to HIV risk. The Megasphaera rtPCR was a combined assay detecting vaginal Megasphaera types 1 and 2, both of which have been linked to bacterial vaginosis. The Prevotella rtPCR was a genus-directed assay. This approach was chosen on the basis of pyrosequencing data, in which higher relative abundance of Prevotella timonensis, P bivia, and additional undifferentiated Prevotella taxa were all associated with similarly increased odds of HIV acquisition. We tested four additional bacteria using rtPCR despite lower score statistics. We included Gardnerella vaginalis because of its longstanding association with bacterial vaginosis and role in biofilm formation. 18 Additionally, we included L crispatus and Lactobacillus jensenii because of their well recognised association with vaginal health. 4, 6 Finally, the relative abundance of Atopobium vaginae was significantly higher in cases versus controls in serodiscordant couples, so rtPCR for this species was done in all cohorts.
In the rtPCR analyses, each bacterial taxon was analysed as a four-category exposure, including undetectable (reference category), first tertile, second tertile, and third tertile of concentrations. The one exception was the Prevotella genus, which had few undetectable samples, so was modelled in four quartiles. Conditional logistic regression was used to generate ORs and 95% CIs testing the hypothesis that increasing quantities of the targeted bacteria were associated with increased or decreased risk for HIV acquisition. Regression models were stratified by cohort to address clustering of individuals within cohorts. The modelling approach assumed a baseline odds for each cohort cluster. This was treated as a nuisance parameter (ie, a parameter not of direct interest but must be accounted for) and conditioned out of the likelihood in the conditional logistic regression models. 19 For each of 20 bacterial taxa in this primary analysis, a single joint p value was used to assess the significance of the overall association between bacterial quantity and HIV acquisition.
We selected potential confounders of the association between vaginal bacterial concentrations and HIV acquisition a priori on the basis of biologically plausible confounding effects. These included age (continuous), pregnancy and contraceptive status (categorical), number of sexual partners in the past month (continuous), 
Median frequency of sex in the past month † To illustrate the difference in HIV risk associated with individual bacterial taxa compared with microscopic criteria for bacterial vaginosis used in earlier studies, we repeated analyses using Nugent scores, 20 comparing normal microbiota (scores 0-3) to intermediate microbiota (scores 4-6) and bacterial vaginosis (scores 7-10).
To examine the effect of the two-step experimental approach using analysis of pyrosequencing data to generate hypotheses for further investigation using rtPCR assays, we evaluated the association between detection of individual taxa with use of rtPCR assays and HIV acquisition in a validation subset of 128 women not included in the relative abundance analysis. Because the validation sample was independent of that used in the pyrosequencing analysis, it was possible to apply a Benjamini-Hochman false discovery rate of 0·20 to the 20 bacterial taxa examined. Three adjustments were made to the analytical approach because of the smaller dataset. First, this analysis used detection rather than quantiles of each bacterial taxon. Second, confounders in the multivariable model were restricted to age, pregnancy or contraceptive status, and recent unprotected intercourse. Third, a firth logistic regression was used to generate 95% CIs and p values if data were sparse (expected cell count less than five in a cross tabulation of exposure and outcome).
We did sensitivity analyses, focusing on bacteria significantly associated with HIV acquisition in the primary analysis. First, analyses were repeated with the female sex worker cohort, pregnant or post-partum cohort, and HIV-serodiscordant couples cohorts separately to assess whether results were similar in each population. Second, since vaginal microbiota change over time, the primary analysis was repeated after excluding cases and their matched controls in which the case sample was collected more than 90 days before the first visit where HIV infection was identified. Third, the analysis was repeated after excluding cases sampled during acute or early HIV infection and their controls. Fourth, because inflammation caused by classical sexually transmitted infections might abrogate an effect of vaginal microbiota on HIV susceptibility mediated through an inflammatory mechanism, analyses were repeated in the subset of women without Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis detected at the study visit. Fifth, because vaginal washing is a suspected risk factor for both HIV acquisition and bacterial vaginosis, 21, 22 an analysis adjusting for vaginal washing status was done in the subset of women in which these data were captured. Finally, analyses were repeated after stratifying by sample collection method (vaginal vs cervical swab).
We did the analyses using IBM SPSS Statistics (version 23), Stata (version 13), and R (version 3.3.2) using the ggplot2 and RColorBrewer packages.
Role of the funding source
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. One woman in the Partners in Prevention HSV/HIV Study was not examined for genital ulceration and cervical mucopus. ¶n=294 for full cohort (n=74 cases and n=220 controls) and n=92 for deep sequencing subset (n=47 cases and n=45 controls). ||n=293 for full cohort (n=73 cases and n=220 controls) and n=92 for deep sequencing subset (n=47 cases and n=45 controls). **Not available for the Couples Observational Study and missing for 11 women from other cohorts. n=306 for full cohort (n=76 cases and n=230 controls) and n=106 for deep sequencing subset (n=54 cases and n=52 controls). † †n=262 for full cohort (n=68 cases and n=194 controls) and n=86 for deep sequencing subset (n=45 cases and n=41 controls). 74 women in the Mama Salama Study were not assessed for Neisseria gonorrhoeae at the swab collection date (per study schedule), and N gonorrhoeae swabs are missing for 13 women from other cohorts. ‡ ‡n=239 for full cohort (n=60 cases and n=179 controls) and n=77 for deep sequencing subset (n=40 cases and n=37 controls). 74 women in the Mama Salama Study and 23 women in the Mombasa Cohort were not assessed for Chlamydia trachomatis at the swab collection date (per study schedules), and C trachomatis swabs are missing for 13 women from other cohorts. § §n=339 for full cohort (n=85 cases and n=254 controls) and n=110 for deep sequencing subset (n=55 cases and n=55 controls). Samples were missing for ten women from the Partners in Prevention HSV/HIV Study, Couples Observational Study, and Partners PrEP Study. ¶ ¶n=196 for full cohort (n=45 cases and n=151 controls) and n=51 for deep sequencing subset (n=24 cases and n=27 controls). Syphilis status at the study visit was not available for the Mama Salama Study and was not available at the study visit for 41 women from the other cohorts. ||||n=198 for full cohort (n=50 cases and n=148 controls) and n=65 for deep sequencing subset (n=34 cases and n=31 controls). HSV-2 serostatus was not available for the Mama Salama Study and was missing for 39 women from the other cohorts. ***n=152 for full cohort (n=38 cases and n=114 controls) and n=54 for deep sequencing subset (n=27 cases and n=27 controls). Yeast data were not available for the Partners in Prevention HSV/HIV Study, Couples Observational Study, and Partners PrEP study. † † †n=192 for full cohort (n=49 cases and n=143 controls) and n=76 for deep sequencing subset (n=38 cases and n=38 controls). Antibiotic use data were not available for the Partners in Prevention HSV/HIV Study or the Couples Observational Study. Data on antibiotic use in the past 90 days were not available for the study visit for 73 women from the other cohorts. In the Partners PrEP Study, only antibiotics provided for sexually transmitted infections were captured. Table 2 presents the baseline characteristics.
Results
Between
The appendix (p 22) shows the overall vaginal bacterial community diversity in 55 cases versus 55 controls evaluated by pyrosequencing. The Shannon Diversity Index was significantly higher in cases (median 1·3, IQR 0·4-2·3) than in controls (0·7, 0·1-1·5; p=0·03). Community richness, using the Chao1 Index, was also higher in cases (median 38·5, IQR 14·0-59·0) than in controls (25·0, 10·0-54·2), although this difference was not significant (p=0·17). Histograms illustrating Shannon and Chao1 distributions are shown in the appendix (p 23).
Relative abundance of individual bacterial taxa was compared between cases and controls. Table 3 summarises the taxa that showed a statistical trend towards an association with HIV acquisition (p<0·15). Higher relative abundance of Dialister genus (OR 2·17, 95% CI 1·04-4·53), Dialister species type 2 (1·85, 1·11-3·08), Dialister micraerophilus (1·62, 1·03-2·53), Gemella asaccharolytica (12·01, 2·26-63·78), Eggerthella species type 1 (2·06, 1·23-3·45), Parvimonas micra (3·26, 1·17-9·07), and Leptotrichia amnionii (2·67, 1·26-5·65) was associated with significantly higher odds of HIV acquisition. By contrast, higher relative abundance of Lactobacillus iners (OR 0·54, 95% CI 0·36-0·80) was associated with significantly lower odds of HIV acquisition.
In the univariate analyses of the 20 taxa selected for rtPCR testing, Parvimonas species type 1, G asaccharolytica, Mycoplasma hominis, Leptotrichia/Sneathia, Porphyromonas species type 1, Parvimonas species type 2, G vaginalis, Eggerthella species type 1, and Megasphaera showed significant associations with HIV acquisition (table 4) . Results were similar after adjustment for potential confounders, although G vaginalis and Porphyromonas species type 1 were no longer significantly associated with HIV acquisition. Four taxa, Parvimonas species type 1 (first tertile adjusted OR [aOR] 1·67, 95% CI 0·61-4·57; second tertile 3·01, 1·13-7·99; third tertile 4·64, 1·73-12·46; p=0·005), G asaccharolytica (first tertile 2·09, 1·01-4·36; second tertile 2·02, 0·98-4·17; third tertile 3·03, 1·46-6·30; p=0·010), M hominis (first tertile 1·46, 0·69-3·11; second tertile 1·40, 0·66-2·98; third tertile 2·76, 1·36-5·63; p=0·048), and Leptotrichia/Sneathia (first tertile 2·04, 1·02-4·10; second tertile 1·45, 0·70-3·00; third tertile 2·59, 1·26-5·34; p=0·046), showed associations that were strongest at the highest concentrations. Figure 1 shows the aORs for the highest quantile of each taxon, and illustrates how some species typically associated with vaginal dysbiosis and bacterial vaginosis were strongly associated with HIV acquisition, whereas other bacterial species were not. This analysis identified individual bacterium-specific associations despite strong correlations between many bacteria included in the rtPCR analyses (figure 2).
In the validation subset, after adjustment for potential confounding factors and a 20% false discovery rate, detection by rtPCR was associated with higher odds of HIV acquisition for five of the seven bacteria that showed concentration-related associations in the primary analysis (appendix pp 10, 11): M hominis (aOR 2·71, 95% CI 1·13-6·49; p=0·026), Eggerthella species type 1 (2·50, 1·07-5·85; p=0·035), Leptotrichia/Sneathia (2·47, 0·98-6·22; p=0·056), G asaccharolytica (2·45, 1·04-5·78; p=0·040), and Parvimonas species type 2 (2·43, 1·03-5·70; p=0·042).
The Nugent scoring system was applied to 76 cases and 230 controls with vaginal Gram stains available. Compared with women with normal microbiota, those with intermediate microbiota (aOR 2·50, 95% CI 1·15-5·40) and bacterial vaginosis (2·10, 1·14-3·88) had increased risk for HIV acquisition (joint test p=0·018).
Several sensitivity analyses were applied to the seven bacterial taxa associated with HIV acquisition in our primary multivariable analysis. Associations were similar in female sex workers, pregnant and post-partum women, and serodiscordant couples (appendix p 12), despite the differences in demographics, risk factors, and Gemella asaccharolytica
Eggerthella species type 1 0 (0-2·47)
Parvimonas micra
Dialister micraerophilus
Lactobacillus reuteri/ Lactobacillus vaginalis
Prevotella timonensis
Mycoplasma hominis
Corynebacterium amycolatum
Megasphaera species type 1 0 (0-17·76)
Data are median (range), unless otherwise stated. Only bacterial taxa that were associated with HIV acquisition with p≤0·15 were included. BVAB2=bacterial vaginosis associated bacterium 2. *Some taxa were identified only to the genus level, whereas others were identified to the species level. In instances for which this level of identification was used, the genus level group excluded the individual species that were identified separately. †OR and CI are highly sensitive to two outlier Mycoplasma values; when these values are removed, the OR was 30·23 (95% CI 0·93-984·53; p=0·06). incidence observed in these cohorts (table 1) . Additionally, analyses limited to cases where samples were collected less than 90 days before identification of HIV infection, excluding cases with samples from acute HIV infection, excluding cases with sexually transmitted infections, incorporating adjustment for vaginal washing, or stratifying by swab collection method had similar point estimates compared with the primary analyses; however, despite the similar point estimates, some associations were no longer significant, possibly because of the smaller sample sizes in these subset analyses (appendix pp 13-21).
Discussion
Using two sophisticated bacterial PCR approaches and data from five cohorts spanning six sub-Saharan African countries, this study was the first to show significant associations between the quantity of specific vaginal bacteria and women's risk of HIV acquisition. Concentrations of Parvimonas species types 1 and 2, G asaccharolytica, M hominis, Leptotrichia/Sneathia, Eggerthella species type 1, and Megasphaera were significantly associated with increased HIV risk. There were strong correlations between concentrations of many of the 20 bacteria evaluated with rtPCR, suggesting they might frequently be found together, establishing high-risk bacterial communities. These findings were consistent across three distinct risk groups: female sex workers, pregnant and post-partum women, and women in serodiscordant relationships.
Vaginal microbiota could influence women's risk of HIV acquisition at multiple levels. 23 First, genital inflammation, mediated by the presence of particular bacterial taxa or communities, is likely to influence HIV susceptibility. 9, 24 A recent study identified six vaginal bacterial genera independently associated with proinflam matory cytokines. 5 Two of these genera, Sneathia and Gemella, correspond to vaginal bacteria showing concentration-dependent associations with HIV risk in the present analysis. Second, vaginal dysbiosis has been associated with HIV-inducing factors in vaginal fluid. 25 Third, many bacteria associated with bacterial vaginosis produce sialidases and mucinases that disrupt the protective cervicovaginal mucus layer. 7 In one earlier study, the presence of cultivable Lactobacillus species was associated with a decreased risk of acquiring HIV. 26 Additionally, a recent study using molecular characterisation of vaginal microbiota found that women with vaginal bacterial communities deficient in non-iners species of Lactobacillus were at increased risk for HIV infection. 9 The present analysis showed an association between lower relative abundance of L iners and HIV acquisition. However, the primary analysis using rtPCR assays in the full dataset showed no significant associations between concentrations of Lactobacillus species (L iners, L crispatus, and L jensenii) and HIV acquisition. Given the negative correlations between concentrations of lactobacilli and bacterial vaginosis-associated species, low relative abundance of Lactobacillus species might simply reflect the presence of high concentrations of bacterial vaginosis-associated bacteria that affect HIV susceptibility. This study used a novel sequential experimental approach that used complementary methods to evaluate the vaginal microbiome. In the first step, relative abundance data were used to show the association between vaginal bacterial diversity and HIV acquisition, and to guide selection of a restricted set of bacteria for further investigation. In the second step, highly sensitive taxon-directed rtPCR assays were used to test the hypothesis that concentrations of 20 key bacteria would be associated with HIV risk. The two steps captured related but distinct exposures. Specifically, relative abundance is not the same as absolute quantity of a bacterial taxon. Additionally, the rtPCR assays are more sensitive but might be less specific for detection of individual bacteria than use of broad range PCR with pyrosequencing.
This study included a validation analysis in a subset of samples that were not included in the pyrosequencing step, facilitating independent testing of hypotheses generated from pyrosequencing data. Two important points should be considered in comparing the primary analysis with the validation analysis. First, because of the smaller sample size in the validation analysis than in the primary analysis, bacterial taxa were modelled in a binary fashion rather than as four quantiles. Second, the validation subset was not a randomly generated group of cases and controls, so distribution across the five cohorts diverged from that of the full dataset. Despite these caveats, the validation confirmed an association between bacterial taxa and HIV acquisition for five of the seven bacteria identified in the primary analysis.
An important strength of this study was the large and geographically diverse sample, with individuals representing three distinct risk groups. A further strength in the study design was the collection of vaginal microbiota samples before HIV acquisition in more than 80% of cases, and shortly after HIV acquisition in the remainder of cases. Furthermore, the analyses were robust in multiple sensitivity analyses testing assumptions in the experimental approach. This study also had limitations. First, as an observational study, these analyses do not provide definitive evidence that the associations detected are caused by bacteria increasing HIV susceptibility. Second, these analyses did not explore mechanisms through which individual bacterial taxa might increase HIV risk. Such mechanistic data will help to further evaluate the likelihood of a causal link between vaginal bacteria and HIV susceptibility, and will be the focus of future studies. Third, despite adjustment for potential confounding factors, residual confounding is possible because of measurement error or unmeasured confounding factors. Fourth, longer intervals between sample collection and HIV acquisition could attenuate the observed associations, 27 although this source of variability was minimised by avoiding sample collection during menses. Fifth, sampling methods and laboratory procedures varied across the five cohorts included in this analysis. Related to this point, laboratory data on sexually transmitted infections and vaginal yeast were not available at all analysis visits, so the primary analysis does not include adjustment for these conditions. Finally, despite inclusion of multiple risk groups in this study, all participants were from eastern and southern Africa. Although this represents the region affected the most by the HIV epidemic, the findings might not be generalisable to all geographical regions.
Higher diversity vaginal bacterial communities not dominated by lactobacilli are more common in African and Hispanic women than in women of Asian or European origin, 4, 28 leading to the hypothesis that racial differences in vaginal microbiota might contribute to population-level differences in HIV transmission and prevalence. 29 Underlining this point, recent studies suggest that vaginal dysbiosis accounts for 20-30% of the population attributable risk of HIV acquisition in African women. 30, 31 Because bacterial vaginosis is an extremely heterogeneous condition, 3, 4 defining individual vaginal bacteria that are associated with HIV risk in women could provide additional specific targets and inform future strategies for HIV prevention research.
